Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - ScienceDirect
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine
Momenta ramps up biosim pressure on AbbVie's Humira with phase 3 psoriasis win | Fierce Pharma
Adalimumab | Crohn's & Colitis UK
Immunopharmacologic Monitoring of Therapeutic Serum Antibodies I. Policy Description II. Related Policies III. Indications and/o
Selection of TNF inhibitor. a For example, complete blood count,... | Download Scientific Diagram
Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and antiв•'adalimumab in patients
Frontiers | The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring
Tailoring anti-TNF therapy in IBD: drug levels and disease activity | Nature Reviews Gastroenterology & Hepatology
Adalimumab | BIDMC
Medical Tests to Get Before Starting Biologics
TNFα Therapeutic Drug Monitoring - Calprotectin
Monitoring your medication | Crohn's & colitis
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Striking a new path – extending the diagnostic portfolio by test systems for therapeutic drug monitoring - EUROIMMUNBlog
Available now: The complete package for Therapeutic Drug Monitoring
Clinical Specialist Services Care Group Department of Pathology - Immunology ADALIMUMAB MONITORING Includes: Serum adalimumab, a
Monitoring of Novel Therapies in Rheumatology | RheumNow
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
POS0621 DISEASE-SPECIFIC ADVERSE DRUG REACTION PROFILES OF ADALIMUMAB AND ETANERCEPT AS REPORTED BY IMMUNE-MEDIATED INFLAMMATORY DISEASE PATIENTS | Annals of the Rheumatic Diseases
Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology
